Answers are grounded in this paper and cite their sources.
Microneedle (MN) biosensors offer a minimally invasive approach for molecular analysis of interstitial fluid (ISF), but multiplexed detection of low-abundance protein biomarkers remains limited by poor spatial functionalization and analytical sensitivity. Here, we introduce a high-resolution transfer-printing strategy that functionalizes individual MNs with distinct biorecognition elements on a single patch, enabling simultaneous capture and on-needle analysis of multiple protein biomarkers. Combined with plasmonic-enhanced ultrabright fluorescent nanolabels, the platform enables sensitive multiplexed quantification of low-abundance immune and kidney function biomarkers in mouse models and human subjects. ISF biomarker concentrations showed strong correlations with corresponding plasma levels, supporting the physiological relevance of MN-based measurements. The MN patch enabled painless, blood-free sampling with rapid skin recovery and no irritation. This scalable platform provides a versatile approach for minimally invasive biomarker profiling and may facilitate frequent disease monitoring and timely clinical decision-making.
No takes yet. Share an insight, caveat, or question.
Ravi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: